158 related articles for article (PubMed ID: 17913045)
1. IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients.
Carpagnano GE; Spanevello A; Curci C; Salerno F; Palladino GP; Resta O; Di Gioia G; Carpagnano F; Foschino Barbaro MP
Oncol Res; 2007; 16(8):375-81. PubMed ID: 17913045
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Resta O; Gramiccioni E; Carpagnano F
Oncology; 2004; 66(3):180-4. PubMed ID: 15218307
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer.
Brussino L; Culla B; Bucca C; Giobbe R; Boita M; Isaia G; Heffler E; Oliaro A; Filosso P; Rolla G
J Breath Res; 2014 Jun; 8(2):027110. PubMed ID: 24861949
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC).
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():123-35. PubMed ID: 9337531
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
Huang F; Wang XL; Geng Y; Li MX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
Tas F; Duranyildiz D; Argon A; Oğuz H; Camlica H; Yasasever V; Topuz E
Med Oncol; 2005; 22(4):353-8. PubMed ID: 16260852
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer.
Carpagnano GE; Resta O; Foschino-Barbaro MP; Gramiccioni E; Carpagnano F
Int J Biol Markers; 2002; 17(2):141-5. PubMed ID: 12113582
[TBL] [Abstract][Full Text] [Related]
8. [Markers of fibrosis and inflammation in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) of patients with pulmonary sarcoidosis -- a pilot study].
Kowalska A; Puścińska E; Czerniawska J; Goljan-Geremek A; Czystowska M; Rozy A; Chorostowska-Wynimko J; Górecka D
Pneumonol Alergol Pol; 2010; 78(5):356-62. PubMed ID: 20703999
[TBL] [Abstract][Full Text] [Related]
9. CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.
Zou Y; Wang L; Zhao C; Hu Y; Xu S; Ying K; Wang P; Chen X
J Breath Res; 2013 Dec; 7(4):047101. PubMed ID: 24185583
[TBL] [Abstract][Full Text] [Related]
10. Detection of tumor necrosis factor-α and interleukin-6 in exhaled breath condensate of rats with pneumonia due to staphylococcal enterotoxin B.
Heidemann SM; Sandhu H; Kovacevic N; Phumeetham S; Solomon R
Exp Lung Res; 2011 Nov; 37(9):563-7. PubMed ID: 21967195
[TBL] [Abstract][Full Text] [Related]
11. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
[TBL] [Abstract][Full Text] [Related]
12. Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.
Song XY; Zhou SJ; Xiao N; Li YS; Zhen DZ; Su CY; Liu ZD
Asian Pac J Cancer Prev; 2013; 14(8):4765-8. PubMed ID: 24083740
[TBL] [Abstract][Full Text] [Related]
13. Exhaled matrix metalloproteinase-9 in lung cancer.
Carpagnano GE; Palladino GP; Martinelli D; Lacedonia D; Orlando S; Foschino-Barbaro MP
Rejuvenation Res; 2012 Aug; 15(4):359-65. PubMed ID: 22877564
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
Küpeli E; Karnak D; Beder S; Kayacan O; Tutkak H
Respiration; 2008; 75(1):73-8. PubMed ID: 17975298
[TBL] [Abstract][Full Text] [Related]
15. Correlation Between Tumor Necrosis Factor-α and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function.
Lin X; Fan Y; Wang X; Chi M; Li X; Zhang X; Sun D
Am J Med Sci; 2017 Oct; 354(4):388-394. PubMed ID: 29078843
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer.
Zhou F; Chen J; Tao G; Zhu M; Xie W; Cao X
Respir Med; 2014 Nov; 108(11):1670-6. PubMed ID: 25179787
[TBL] [Abstract][Full Text] [Related]
17. The role of obstructive sleep apnea syndrome and obesity in determining leptin in the exhaled breath condensate.
Carpagnano GE; Resta O; Pergola GD; Sabato R; Foschino Barbaro MP
J Breath Res; 2010 Sep; 4(3):036003. PubMed ID: 21383480
[TBL] [Abstract][Full Text] [Related]
18. Clinical Implications of Hepatocyte Growth Factor, Interleukin-20, and Interleukin-22 in Serum and Bronchoalveolar Fluid of Patients with Non-Small Cell Lung Cancer.
Naumnik W; Naumnik B; Niklińska W; Ossolińska M; Chyczewska E
Adv Exp Med Biol; 2016; 952():41-49. PubMed ID: 27573644
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic markers in breath condensate identify non-small cell lung cancer.
Gessner C; Rechner B; Hammerschmidt S; Kuhn H; Hoheisel G; Sack U; Ruschpler P; Wirtz H
Lung Cancer; 2010 May; 68(2):177-84. PubMed ID: 19647334
[TBL] [Abstract][Full Text] [Related]
20. Eicosanoids in exhaled breath condensate and bronchoalveolar lavage fluid of patients with primary lung cancer.
Ciebiada M; Górski P; Antczak A
Dis Markers; 2012; 32(5):329-35. PubMed ID: 22674413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
